Robin Hofmann

2.5k total citations · 1 hit paper
62 papers, 906 citations indexed

About

Robin Hofmann is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Emergency Medicine. According to data from OpenAlex, Robin Hofmann has authored 62 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cardiology and Cardiovascular Medicine, 17 papers in Surgery and 11 papers in Emergency Medicine. Recurrent topics in Robin Hofmann's work include Acute Myocardial Infarction Research (25 papers), Heart Failure Treatment and Management (10 papers) and Cardiac Arrest and Resuscitation (10 papers). Robin Hofmann is often cited by papers focused on Acute Myocardial Infarction Research (25 papers), Heart Failure Treatment and Management (10 papers) and Cardiac Arrest and Resuscitation (10 papers). Robin Hofmann collaborates with scholars based in Sweden, United Kingdom and Germany. Robin Hofmann's co-authors include Tomas Jernberg, David Erlinge, Bertil Lindahl, Joakim Alfredsson, Magnus Bäck, Per Svensson, Troels Yndigegn, Karolina Szummer, Annica Ravn‐Fischer and Stefan James and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Robin Hofmann

54 papers receiving 897 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

2024 99 citations Troels Yndigegn, Bertil Lindahl et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robin Hofmann Sweden	17	546	219	158	95	92	62	906
Neal A. Chatterjee United States	21	852 1.6×	108 0.5×	60 0.4×	77 0.8×	70 0.8×	64	1.1k
Kenan Yalta Türkiye	16	501 0.9×	179 0.8×	93 0.6×	184 1.9×	29 0.3×	82	814
Henry D. Huang United States	17	759 1.4×	261 1.2×	164 1.0×	46 0.5×	39 0.4×	77	1.0k
Pattara Rattanawong United States	19	701 1.3×	132 0.6×	86 0.5×	52 0.5×	30 0.3×	96	1.1k
Mehrtash Hashemzadeh United States	16	661 1.2×	269 1.2×	109 0.7×	204 2.1×	27 0.3×	67	1.1k
Danielle Morris United States	18	355 0.7×	368 1.7×	118 0.7×	180 1.9×	123 1.3×	45	998
Ahmet Duran Demir Türkiye	17	437 0.8×	188 0.9×	96 0.6×	153 1.6×	28 0.3×	81	792
Mahesh Bikkina United States	16	840 1.5×	240 1.1×	179 1.1×	160 1.7×	48 0.5×	73	1.1k
Andrew Goodwin United Kingdom	18	454 0.8×	346 1.6×	35 0.2×	278 2.9×	83 0.9×	61	917
Kuljit Singh Australia	16	918 1.7×	357 1.6×	407 2.6×	86 0.9×	57 0.6×	54	1.2k

Countries citing papers authored by Robin Hofmann

Since Specialization

Citations

This map shows the geographic impact of Robin Hofmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Hofmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Hofmann more than expected).

Fields of papers citing papers by Robin Hofmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Hofmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Hofmann. The network helps show where Robin Hofmann may publish in the future.

Co-authorship network of co-authors of Robin Hofmann

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Hofmann. A scholar is included among the top collaborators of Robin Hofmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Hofmann. Robin Hofmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hofmann, Robin, Martin Jönsson, Aristomenis Manouras, et al.. (2025). The prognostic value of global longitudinal strain in patients with myocardial infarction and preserved ejection fraction: a prespecified substudy of the REDUCE-AMI trial. European Heart Journal - Cardiovascular Imaging. 26(4). 620–627. 1 indexed citations

Glynn, L. E., Marcus Lind, Tomas Andersson, et al.. (2024). Trends in Survival After First Myocardial Infarction in People With Diabetes. Journal of the American Heart Association. 13(10). e034741–e034741. 2 indexed citations

Ömerovic, Elmir, Truls Råmunddal, Pétur Pétursson, et al.. (2024). Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registry. European Heart Journal. 46(6). 518–531. 7 indexed citations

Matthews, Anthony, Conor‐James MacDonald, Bertil Lindahl, et al.. (2024). Prospective benchmarking of an observational analysis in the SWEDEHEART registry against the REDUCE-AMI randomized trial. European Journal of Epidemiology. 39(4). 349–361. 7 indexed citations

Andell, Pontus, Joakim Alfredsson, David Erlinge, et al.. (2024). Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study. Circulation. 150(11). 826–835. 6 indexed citations

Nordberg, Per, et al.. (2023). Association Between CKD, Obesity, Cardiometabolic Risk Factors, and Severe COVID-19 Outcomes. Kidney International Reports. 8(4). 775–784. 4 indexed citations

Hofmann, Robin, et al.. (2023). Helicobacter Pylori Virulence Factor Cytotoxin-Associated Gene A (CagA) Induces Vascular Calcification in Coronary Artery Smooth Muscle Cells. International Journal of Molecular Sciences. 24(6). 5392–5392. 7 indexed citations

Hjort, Marcus, Stefan Agewall, Olov Collste, et al.. (2023). Helicobacter pylori and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery Disease. International Journal of Molecular Sciences. 24(18). 14143–14143. 5 indexed citations

Hofmann, Robin & Magnus Bäck. (2023). Time for Routine Helicobacter pylori Screening in Coronary Artery Disease?. Circulation. 147(23). 1731–1733. 6 indexed citations

10.

Hofmann, Robin, et al.. (2023). Randomized evaluation of routine beta-blocker therapy after myocardial infarction quality of life (RQoL): design and rationale of a multicentre, prospective, randomized, open, blinded endpoint study. European Heart Journal Open. 3(3). oead036–oead036. 3 indexed citations

11.

Wallert, John, et al.. (2022). Association between β-blocker dose and quality of life after myocardial infarction: a real-world Swedish register-linked study. European Heart Journal Acute Cardiovascular Care. 11(6). 491–500. 3 indexed citations

12.

Yndigegn, Troels, Bertil Lindahl, Joakim Alfredsson, et al.. (2022). Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI). European Heart Journal - Cardiovascular Pharmacotherapy. 9(2). 192–197. 15 indexed citations

13.

Jernberg, Tomas, et al.. (2021). Incidence, associated outcomes, and predictors of upper gastrointestinal bleeding following acute myocardial infarction: a SWEDEHEART-based nationwide cohort study. European Heart Journal - Cardiovascular Pharmacotherapy. 8(5). 483–491. 30 indexed citations

14.

Alfredsson, Joakim, Stefan James, David Erlinge, et al.. (2021). Randomized comparison of early supplemental oxygen versus ambient air in patients with confirmed myocardial infarction: Sex-related outcomes from DETO2X-AMI. American Heart Journal. 237. 13–24. 2 indexed citations

15.

Völz, Sebastian, Björn Redfors, Oskar Angerås, et al.. (2021). Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). European Heart Journal. 42(27). 2657–2664. 36 indexed citations

16.

Pawelzik, Sven‐Christian, David Erlinge, Tomas Jernberg, et al.. (2020). Helicobacter pylori screening in clinical routine during hospitalization for acute myocardial infarction. American Heart Journal. 231. 105–109. 18 indexed citations

17.

Wallert, John, Claes Held, Ronnie Pingel, et al.. (2020). Association between β-blocker dose and cardiovascular outcomes after myocardial infarction: insights from the SWEDEHEART registry. European Heart Journal Acute Cardiovascular Care. 10(4). 372–379. 14 indexed citations

18.

Nyström, Thomas, Stefan James, Bertil Lindahl, et al.. (2019). Oxygen Therapy in Myocardial Infarction Patients With or Without Diabetes: A Predefined Subgroup Analysis From the DETO2X-AMI Trial. Diabetes Care. 42(11). 2032–2041. 5 indexed citations

19.

Wallentin, Lars, Joakim Alfredsson, David Erlinge, et al.. (2019). Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry. European Heart Journal. 41(7). 833–843. 46 indexed citations

20.

Hofmann, Robin, Per Tornvall, Nils Witt, et al.. (2017). Supplemental oxygen therapy does not affect the systemic inflammatory response to acute myocardial infarction. Journal of Internal Medicine. 283(4). 334–345. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact